2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theChronic Kidney Disease Market?

The escalating incidence of kidney disease is projected to fuel the expansion of the chronic kidney disease market in the future. This refers to a set of disorders that impact the kidneys’ functionality and structure. Medicine for kidney disease aims to regulate patients’ blood pressure and reduce protein loss, thereby slowing kidney decay, treating symptoms, and preventing complications. For instance, data from July 2022 by the Centers for Disease Control and Prevention, a US-based national public health organization, stated that kidney disease touched around 15% or 37 million individuals in the US. Thus, the escalating incidence of kidney disease is propelling the growth of the chronic kidney disease market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

#How Does the Projected Chronic Kidney Disease Market Growth Compare Over the Forecast Period?

The market size of chronic kidney disease has seen robust growth in the past few years. The market, which was valued at $70.65 billion in 2024, is expected to upscale to $75.09 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.3%. Factors that have contributed to the historical growth trend comprise the prevalence of hypertension and diabetes, an aging population, unhealthy lifestyles, healthcare access disparities, and advancements in medical science.

Predictions indicate a robust expansion in the chronic kidney disease market in the coming years, with an estimation to reach a market value of $95.85 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.3%. This anticipated advancement during the forecast period can be credited to factors such as a concentrated healthcare policy, the evolution of precision medicine, increasing rates of obesity, the rise of chronic diseases, and enhanced access to healthcare. The forecast period is also likely to witness significant trends like early detection initiatives, the incorporation of telemedicine and remote patient monitoring, programs fostering patient empowerment, community-oriented care strategies, and the implementation of nutritional therapy.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969

What Are the Current Market Growth and Trends in theChronic Kidney Disease Market That Industry Players Should Watch?

One significant trend gaining traction in the chronic kidney disease market is product innovations. Companies in this industry are creating novel products to maintain their market dominance. For instance, Bayer, a biotechnology and pharmaceutical firm based in Germany, introduced the inventive medication Kerendia (finerenone) in August 2022. This medication aims to slow the progression of chronic kidney disease in individuals with diabetes. As a first-in-class non-steroidal, selective mineralocorticoid receptor antagonist, it differs from current treatments as it can block the overactivation of the mineralocorticoid receptor (MR), a factor that contributes to the progression of CKD and cardiovascular damage.

What Are the Major Market Players Making an Impact on theChronic Kidney Disease Market Growth?

Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

How Are the Key Segments of the Chronic Kidney Disease Market Driving Opportunities and Innovations?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theChronic Kidney Disease Market?# Market Expansion?

North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Chronic Kidney Disease Maret 2025, By The Business Research Company:

Styrene Butadiene Rubber (SBR) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/styrene-butadiene-rubber-sbr-global-market-report

Ethylene Propylene (EPDM) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ethylene-propylene-epdm-global-market-report

Polymer Biomaterial Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/polymer-biomaterial-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: